Genetic susceptibility to multiple sclerosis: interactions between conserved extended haplotypes of the MHC and other susceptibility regions

por Goodin, D. S., Khankhanian, P., Gourraud, P. A., Vince, N.
Publicado 2021

16(th) IHIW: Global analysis of registry HLA haplotypes from 20 Million individuals: Report from the IHIW Registry Diversity Group

por Maiers, M, Gragert, L, Madbouly, A, Steiner, D, Marsh, S G E, Gourraud, P-A, Oudshoorn, M, Zanden, H, Schmidt, A H, Pingel, J, Hofmann, J, Müller, C, Eberhard, H-P
Publicado 2013

Protocol of a multicentric prospective cohort study for the VALIDation of the IBD-disk instrument for assessing disability in inflammatory bowel diseases: the VALIDate study

por Le Berre, C., Bourreille, A., Flamant, M., Bouguen, G., Siproudhis, L., Dewitte, M., Dib, N., Cesbron-Metivier, E., Goronflot, T., Hanf, M., Gourraud, P.-A., Kerdreux, E., Poinas, A., Trang-Poisson, C.
Publicado 2020

Correction to: Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1 ≥ 50%

por Pons-Tostivint, E., Hulo, P., Guardiolle, V., Bodot, L., Rabeau, A., Porte, M., Hiret, S., Demontrond, P., Curcio, H., Boudoussier, A., Veillon, R., Mayenga, M., Dumenil, C., Chatellier, T., Gourraud, P. A., Mazieres, J., Bennouna, J.
Publicado 2023

Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1 ≥ 50%

por Pons-Tostivint, E., Hulo, P., Guardiolle, V., Bodot, L., Rabeau, A., Porte, M., Hiret, S., Demontrond, P., Curcio, H., Boudoussier, A., Veillon, R., Mayenga, M., Dumenil, C., Chatellier, T., Gourraud, P. A., Mazieres, J., Bennouna, J.
Publicado 2023